Angiotensin-Converting Enzyme Inhibitor (ACEI)-Mediated Amelioration in Renal Fibrosis Involves Suppression of Mast Cell Degranulation

Publisher： Karger

E-ISSN： 1423-0143|41|1|108-118

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.41, Iss.1, 2016-0, pp. : 108-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Therapy with Angiotensin-Converting Enzyme Inhibitor and Oral Adsorbent of Uremic Toxins Can Delay the Appearance of Glomerular Sclerosis and Interstitial Fibrosis in Established Renal Failure

By  

Kidney and Blood Pressure Research, Vol. 27, Iss. 4, 2004-09 ,pp. : 218-225

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitor Suppresses Tubular Expression of Platelet-Derived Growth Factor and Attenuates Progression of Tubulo-Interstitial Fibrosis in a Nephrotic Mouse Model

By  

Nephron, Vol. 79, Iss. 4, 1998-07 ,pp. : 503-504

Karger

Access to resources Recommend Favorite

Control of High Hematocrit Levels in a Hemodialysis Patient with an Angiotensin-Converting Enzyme Inhibitor

By  

Nephron, Vol. 83, Iss. 2, 1999-09 ,pp. : 181-182

Karger

Access to resources Recommend Favorite

Polymorphism of the Angiotensin-Converting Enzyme Gene in End-Stage Renal Failure Patients

By  

Nephron, Vol. 85, Iss. 1, 2000-04 ,pp. : 54-59

Karger

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Inhibitor, Angiotensin II Receptor Antagonist and Calcium Antagonist on Urinary Podocytes in Patients with IgA Nephropathy

By  

American Journal of Nephrology, Vol. 20, Iss. 5, 2000-11 ,pp. : 373-379

Karger

Access to resources Recommend Favorite